er-086526 and niraparib

er-086526 has been researched along with niraparib* in 1 studies

Other Studies

1 other study(ies) available for er-086526 and niraparib

Article	Year
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. Clinical advances in hematology & oncology : H&O, 2018, Volume: 16, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Capecitabine; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Indoles; Ketones; Mutation; Phthalazines; Piperazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Vinblastine; Vinorelbine	2018

Article

Year

The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.

Clinical advances in hematology & oncology : H&O, 2018, Volume: 16, Issue:5

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Capecitabine; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Indoles; Ketones; Mutation; Phthalazines; Piperazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Vinblastine; Vinorelbine

2018